Clinical Trial Detail

NCT ID NCT02297230
Title Locally Advanced Breast Cancer: Individualized Treatment Based On Tumor Molecular Characteristics
Recruitment Terminated
Gender female
Phase Phase Ib/II
Variant Requirements yes
Sponsors New York University School of Medicine
Indications

Her2-receptor positive breast cancer

Therapies

Capecitabine

Paclitaxel

Paclitaxel + Trastuzumab

Age Groups: adult

Additional content available in CKB BOOST